We previously reported that high levels of GABRA2, GABRA3, GABRB3, GABRG1, and GABRG2 indicated better prognosis in glioma, and GABRB3 was particularly associated with longer OS in patients with lower-grade gliomas [18]. This evidence concerns the gene GABRG1 and central nervous system cancer.